SCHEMBL8508427

SCHEMBL8508427

Nc1cc(OCc2ccc(Cl)cc2)nc(N)n1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.52
▸ MPO P05164 1/20 0.50
▸ NUDT1 P36639 1/20 0.48
▸ TEC P42680 1/20 0.47
▸ HSP90AB1 P08238 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MAOB P27338 4/20 0.44
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ IDO1 P14902 2/20 0.43
▸ AGXT P21549 2/20 0.43
▸ HRH4 Q9H3N8 1/20 0.42
▸ ADORA3 P0DMS8 2/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8509853 0.84 MGMT (0.50) DHFRMPONUDT1MEN1KMT2A
SCHEMBL6266136 0.83 NUDT1 (0.66) DHFRMPONUDT1MAOBLMNA
SCHEMBL14383624 0.77 NUDT1 (0.42) DHFRMPONUDT1HRH4
SCHEMBL2749327 0.76 SMN1; SMN2 (0.51) DHFRNUDT1HSP90AB1MEN1KMT2A
SCHEMBL31141585 0.76 SMN1; SMN2 (0.51) DHFRNUDT1HSP90AB1MEN1KMT2A
SCHEMBL24755030 0.75 SMN1; SMN2 (0.69) DHFRNUDT1HSP90AB1MEN1KMT2A
SCHEMBL21513508 0.75 SMN1; SMN2 (0.50) DHFRNUDT1HSP90AB1MEN1KMT2A
SCHEMBL24895914 0.75 SMN1; SMN2 (0.54) DHFRMPONUDT1HSP90AB1MEN1
SCHEMBL3930094 0.74 NUDT1 (0.62) MPONUDT1HSP90AB1MEN1KMT2A
SCHEMBL23764904 0.72 NUDT1 (0.52) NUDT1HSP90AB1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929046-A Pyrimidine and purine derivatives and their use in treating tumour cells CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1999-07-27 — — US disclosed
Send feedback